Skip to content

efficacy and safety of Isochronal late activation mapping guided SVC isolation

efficacy and safety of Isochronal late activation mapping guided SVC isolation - efficacy and safety of Isochronal late activation mapping guided SVC isolation

Status
Active, not recruiting
Phases
Unknown
Study type
Interventional
Source
JPRN
Registry ID
JPRN-UMIN000046657
Enrollment
200
Registered
2022-01-20
Start date
2022-01-20
Completion date
Unknown
Last updated
2026-06-29

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Atrial fibrillation

Interventions

The electroanatomical maps of SVC and RA during sinus rhythm are constructed by high-density mapping catheter (AdvisorTM HD Grid Mapping Catheter, Abbott, St. Paul, MN) and EnSite X system (Abbott, St

Sponsors

Hiroshima University
Lead Sponsor

Eligibility

Sex/Gender
All

Inclusion criteria

Inclusion criteria: Patients who undergo catheter ablation for atrial fibrillation and meet the following conditions. ? 2nd session ? Persistent atrial fibrillation ? Suspected SVC origin PAC inducing AF

Exclusion criteria

Exclusion criteria: ? Under 20 years old ? Patients undergoing SVC isolation at the time of initial treatment ? Patients with a pacemaker or bradyarrhythmia ? Patients with initial treatment of catheter ablation for paroxysmal atrial fibrillation with no evidence of atrial fibrillation induced by PAC originating from SVC ? Patients with poor SVC potential and no SVC sleeve length ? Others who are deemed inappropriate by the investigator or the research coordinator

Design outcomes

Primary

MeasureTime frame
The completion rate of SVC isolation

Secondary

MeasureTime frame
Procedure time (time from the start of SVC isolation to the completion of isolation), fluoroscopy time, number of RF deliveries, total RF energy, complications (phrenic nerve injury, sinus node injury, SVC stenosis, cardiac tamponade)

Countries

Japan

Contacts

Public ContactNaoto Oguri

Hiroshima University Graduate School of Biomedical and Health Sciences Department of Cardiovascular Medicine

d216209@hiroshima-u.ac.jp082-257-5540

Outcome results

None listed

Source: JPRN (via WHO ICTRP) · Data processed: Jul 3, 2026